With market capitalizations below €40 million, both Modex and IsoTis have lost investors' attention, and have products too small to drive sufficient growth internally. Merging won't solve their size problems immediately, but it gives them a better chance of making the external acquisitions that neither could afford alone.

Diagnostics and Therapeutics based on mitochondrial function. MitoKor studies the DNA found in mitochondria to link diseases to mutations in mitoDNA, and suggests a connection between mitochondrial defects and Alzheimer's and Parkinson's disease.